Catalyst Pharma's market cap is currently $2.45B. The company's EPS TTM is $0.41; its P/E ratio is 12.00; Catalyst Pharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.
